Quantinuum Inc. is the first full-stack trapped-ion company to reach public markets through a traditional listing rather than a blank-check merger, and the June quarter is the first look at whether that listing bought a commercial franchise or a funded science program. Cloud-led revenue accelerated off a still-tiny base while the offering filled the partnership with more than two billion in cash. Public holders own only the Class A sliver of an Up-C whose economics still sit mostly with Honeywell and Cambridge Quantum through Common Units and a tax receivable agreement that routes most future cash tax savings back to those pre-listing owners.
The operating tension is mix, not growth theater. Second-quarter net revenue reached $8 million. That is nearly four times the year-ago quarter, after a first half that still trails last year because a large hardware delivery sat in the prior comparison. Adjusted gross margin held near sixty two percent once stock compensation and amortization are stripped out, while the reported loss exploded because the reorganization triggered hundreds of millions of equity awards. Bookings inside the quarter were only $4 million. Remaining performance obligations near seventy four million, plus post-quarter contracts including the Oracle placement, lift year-to-date bookings near eighty one million.
The live question is whether Helios fidelity, the Oracle cloud placement, and a Commerce Department chips award convert a science franchise into recurring compute revenue before the cash pile is consumed by the Sol and Apollo build. Management set first public-year revenue guidance in a twenty eight to thirty two million band, below last year's thirty one million print and far below the fully distributed equity value the market now assigns. The equity works if bookings convert and the hardware cadence repeats. It fails if the next systems slip and the public stub remains a call option on a Honeywell-controlled partnership.